Literature DB >> 21333681

Why does chronic inflammation persist: An unexpected role for fibroblasts.

Christopher D Buckley1.   

Abstract

One of the most important but as yet unanswered questions in inflammation research is not why inflammation occurs (we all get episodes of self limiting inflammation during the course of our lives) but why it does not resolve. Current models of inflammation stress the role of antigen-specific lymphocyte responses and attempt to address the causative agent. However, recent studies have begun to challenge the primacy of the leukocyte and have instead focused on an extended immune system in which stromal cells, such as fibroblasts play a role in the persistence of the inflammatory lesion. In this review I will illustrate how fibroblasts help regulate the switch from acute resolving to chronic persistent inflammation and provide positional memory during inflammatory responses. In chronic inflammation the normal physiological process of the removal of unwanted inflammatory effector cells becomes disordered, leading to the accumulation of leucocytes within lymphoid aggregates that resemble those seen in lymphoid tissue. I will describe how fibroblasts provide survival and retention signals for leukocytes leading to their inappropriate and persistent accumulation within inflamed tissue.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21333681      PMCID: PMC3110265          DOI: 10.1016/j.imlet.2011.02.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  14 in total

1.  Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.

Authors:  N Amft; S J Curnow; D Scheel-Toellner; A Devadas; J Oates; J Crocker; J Hamburger; J Ainsworth; J Mathews; M Salmon; S J Bowman; C D Buckley
Journal:  Arthritis Rheum       Date:  2001-11

2.  Interferon-beta mediates stromal cell rescue of T cells from apoptosis.

Authors:  D Pilling; A N Akbar; J Girdlestone; C H Orteu; N J Borthwick; N Amft; D Scheel-Toellner; C D Buckley; M Salmon
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

3.  Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium.

Authors:  C D Buckley; N Amft; P F Bradfield; D Pilling; E Ross; F Arenzana-Seisdedos; A Amara; S J Curnow; J M Lord; D Scheel-Toellner; M Salmon
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

4.  Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns.

Authors:  Greg Parsonage; Francesco Falciani; Angela Burman; Andrew Filer; Ewan Ross; Margarita Bofill; Stuart Martin; Mike Salmon; Christopher D Buckley
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

5.  Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display.

Authors:  S Scaife; R Brown; S Kellie; A Filer; S Martin; A M C Thomas; P F Bradfield; N Amft; M Salmon; C D Buckley
Journal:  Rheumatology (Oxford)       Date:  2004-08-03       Impact factor: 7.580

Review 6.  Why does chronic inflammatory joint disease persist?

Authors:  Christopher D Buckley
Journal:  Clin Med (Lond)       Date:  2003 Jul-Aug       Impact factor: 2.659

7.  Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.

Authors:  Paul F Bradfield; Nicole Amft; Elizabeth Vernon-Wilson; Andrew E Exley; Greg Parsonage; G Ed Rainger; Gerard B Nash; Andrew M C Thomas; David L Simmons; Mike Salmon; Christopher D Buckley
Journal:  Arthritis Rheum       Date:  2003-09

8.  Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium.

Authors:  John R MacFadyen; Oliver Haworth; David Roberston; Deborah Hardie; Marie-Therese Webster; Howard R Morris; Maria Panico; Mark Sutton-Smith; Anne Dell; Peter van der Geer; Dirk Wienke; Christopher D Buckley; Clare M Isacke
Journal:  FEBS Lett       Date:  2005-04-07       Impact factor: 4.124

9.  A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis.

Authors:  Angela Burman; Oliver Haworth; Debbie L Hardie; E Nicole Amft; Christiane Siewert; David G Jackson; Mike Salmon; Christopher D Buckley
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 10.  A stromal address code defined by fibroblasts.

Authors:  Greg Parsonage; Andrew D Filer; Oliver Haworth; Gerard B Nash; G Ed Rainger; Michael Salmon; Christopher D Buckley
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

View more
  58 in total

1.  Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor.

Authors:  Puneet S Braich; Robin K Kuriakose; Naveen S Khokhar; Jared C Donaldson; Timothy J McCulley
Journal:  Int Ophthalmol       Date:  2017-06-20       Impact factor: 2.031

2.  PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes.

Authors:  Angel Bottini; Dennis J Wu; Rizi Ai; Michelle Le Roux; Beatrix Bartok; Michele Bombardieri; Karen M Doody; Vida Zhang; Cristiano Sacchetti; Martina Zoccheddu; Ana Lonic; Xiaochun Li; David L Boyle; Deepa Hammaker; Tzu-Ching Meng; Lin Liu; Maripat Corr; Stephanie M Stanford; Myles Lewis; Wei Wang; Gary S Firestein; Yeesim Khew-Goodall; Costantino Pitzalis; Nunzio Bottini
Journal:  Ann Rheum Dis       Date:  2019-02-26       Impact factor: 19.103

3.  Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.

Authors:  Angela Lee; Yu Qiao; Galina Grigoriev; Janice Chen; Kyung-Hyun Park-Min; Sung Ho Park; Lionel B Ivashkiv; George D Kalliolias
Journal:  Arthritis Rheum       Date:  2013-04

4.  Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes.

Authors:  Sook Kyung Chang; Ayano C Kohlgruber; Fumitaka Mizoguchi; Xavier Michelet; Benjamin J Wolf; Kevin Wei; Pui Y Lee; Lydia Lynch; Danielle Duquette; Victòria Ceperuelo-Mallafré; Alexander S Banks; Michael B Brenner
Journal:  J Clin Invest       Date:  2017-07-31       Impact factor: 14.808

5.  Synergy between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of DNase II-/-IFNaR-/- Mice.

Authors:  Rebecca Baum; Kerstin Nündel; Sudesh Pawaria; Shruti Sharma; Patricia Busto; Katherine A Fitzgerald; Ellen M Gravallese; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

6.  Elevated cysteine-rich protein 61 (CCN1) promotes skin aging via upregulation of IL-1β in chronically sun-exposed human skin.

Authors:  Zhaoping Qin; Toru Okubo; John J Voorhees; Gary J Fisher; Taihao Quan
Journal:  Age (Dordr)       Date:  2013-07-24

Review 7.  Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis.

Authors:  Maya H Buch; Stephen Eyre; Dennis McGonagle
Journal:  Nat Rev Rheumatol       Date:  2020-12-08       Impact factor: 20.543

Review 8.  Cytokines in rheumatoid arthritis - shaping the immunological landscape.

Authors:  Iain B McInnes; Christopher D Buckley; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

9.  Modulation of TNF-induced macrophage polarization by synovial fibroblasts.

Authors:  Laura T Donlin; Arundathi Jayatilleke; Eugenia G Giannopoulou; George D Kalliolias; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2014-07-23       Impact factor: 5.422

10.  Vocal fold fibroblasts immunoregulate activated macrophage phenotype.

Authors:  Suzanne N King; Fei Chen; Marie E Jetté; Susan L Thibeault
Journal:  Cytokine       Date:  2012-11-02       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.